Quick Facts

• Targeted Use: Symptomatic relief for certain functional digestive discomforts.
• Key Relief Area: Helps manage abdominal pain and bloating.
• Associated Conditions: Used when abdominal symptoms are accompanied by gas or mild diarrhea.

What Météoxane treats: main uses and benefits

Météoxane is a medication intended for the symptomatic management of certain digestive discomforts. Its primary use is in providing relief from abdominal pain that is linked to a sensation of fullness or gas in the digestive tract. The treatment may be employed when these discomforts include gas emissions, bloating, and may also be associated with mild diarrhea.

The medication is primarily indicated for addressing the functional manifestations of these intestinal disorders. As a treatment, Météoxane works to help reduce the digestive contractions (spasms) that may contribute to the pain. It also functions to help decrease the formation of intestinal gas that results in bloating. The therapeutic aim is to help relieve the primary symptoms and promote overall digestive comfort.

This medication is a component of the supportive treatment approach for functional bowel disorders, where the management goal is the reduction of pain and the normalization of transit, often in conjunction with lifestyle and dietary adjustments.

Eligibility: Who Can and Cannot Use Météoxane?

Météoxane is a combination medicine whose official eligibility profile is defined by the regulatory rules for its active ingredients, Phloroglucinol and Simethicone. The medicine is primarily indicated for use in adults and children over 2 years of age.

Use of Météoxane is contraindicated in several population groups. Patients must not use this medicine if they have a known hypersensitivity or allergy to Phloroglucinol, Simethicone, or any excipients in the product. It is also formally excluded for individuals with pre-existing gastrointestinal conditions such as Intestinal Obstruction or Functional Ileus.

Regulatory authorities also place specific restrictions on its use in special populations.

Eligibility is also affected by certain rare hereditary conditions linked to excipients, such as Phenylketonuria, if the specific formulation contains the relevant substance.

Interactions with other medicines and products

The interaction profile for Météoxane, which contains Phloroglucinol and Simethicone, is based primarily on the known properties of its active ingredients as outlined in official regulatory and authoritative biomedical sources.

Simethicone Component Interactions

Simethicone is generally considered physiologically inert and is not systemically absorbed from the gastrointestinal tract. Consequently, official documentation suggests a limited risk for traditional pharmacokinetic drug-drug interactions (involving absorption, metabolism, or excretion).

However, authoritative sources have documented one specific pharmacokinetic interaction:

• Thyroid Hormone Preparations (e.g., Levothyroxine, Liothyronine): Simethicone may potentially interfere with the absorption of these agents when co-administered. To mitigate the risk of reduced therapeutic effect of the thyroid medicine, the official recommendation is to separate the administration of the simethicone-containing product from the thyroid hormone by at least a four-hour interval.

Phloroglucinol Component Interactions

Official regulatory documentation for Phloroglucinol-containing products states a specific pharmacodynamic interaction related to its mechanism of action as a spasmolytic agent:

• Major Analgesics (e.g., Morphine or Morphine Derivatives): The concomitant use of Phloroglucinol with these analgesic classes is officially discouraged due to their spasmogenic (spasm-inducing) effects, which may counteract or inhibit the smooth-muscle relaxing effect of Phloroglucinol. This represents an antagonism of pharmacologic effect.

Summary of Constraints

The regulatory structure emphasizes two key constraints: a time-separation requirement for certain narrow-therapeutic-index drugs (thyroid hormones) and a do-not-combine constraint with major spasmogenic analgesics to prevent therapeutic failure.

The action of Météoxane is driven by a dual, complementary mechanism that influences two distinct factors in the digestive tract: smooth muscle hypercontractility and entrapped gas.

Modulation of Gastrointestinal Smooth Muscle Tone

The spasmolytic component, Phloroglucinol, exerts a direct musculotropic action by engaging key molecular targets within the smooth muscle cells of the digestive system. Its primary focus is the inhibition of voltage-dependent calcium channels and specific Phosphodiesterase (PDE) enzymes. By suppressing calcium influx and modulating the cAMP/cGMP pathway, this mechanism causes the relaxation of hypercontractile muscle tissue. This mechanism produces a reduction in excessive gut wall tension and aberrant muscle activity.

Physical Alteration of Intestinal Gas

The antiflatulent component, Simethicone, operates via a local physical mechanism as a non-systemic surfactant. It targets the surface tension of the numerous small gas bubbles and foam films trapped within the intestinal contents. By reducing surface tension, Simethicone facilitates the coalescence of these tiny, resilient bubbles into larger, more easily managed gas pockets. This physical change facilitates the elimination of intraluminal gas, a process that alters the mechanical state of the abdomen by resolving the trapped gas volume.

Official Administration Instructions

Météoxane is a combination medicine containing phloroglucinol and simethicone, formulated as capsules for oral use. The instructions for administration define the procedural steps, dosage, and timing of the medicine.

Procedural Structure

To use this medication, it is specified that the capsules should be swallowed whole with a small amount of water. The maximum daily dose for adults should generally not exceed six capsules. The administration is structured as an 'as-needed' regimen linked to a maximum frequency, allowing flexibility based on symptoms while maintaining a safety ceiling.

Special Conditions

The instructions specify that the medicine should be taken at a particular time relative to food (before meals) or in response to a specific condition (at the time of pain). If the maximum dose of six capsules per day is insufficient to achieve relief, or if symptoms persist, the patient is advised to consult a physician. There are no specific preparation steps, such as shaking or dilution, documented for the capsule form.

Météoxane: Recent Clinical Evidence

Evidence for Use in Functional Digestive Symptoms

Research evaluating Météoxane was studied for its authorized use in functional intestinal manifestations, including abdominal discomfort, cramping, and symptoms related to excess gas (meteorism). The primary evidence relies on Randomized Controlled Trials (RCTs) and systematic reviews. Studies explored changes in patient-reported outcomes such as the severity and frequency of abdominal pain, cramping, and bloating in adult populations. For the antispasmodic component, systematic reviews indicate that findings were mixed across some older trials. Research on the antiflatulent component contributed to the broader evidence landscape concerning the study of the component for gas-related symptoms. Evidence is limited for the specific fixed-dose combination in large-scale, contemporary RCTs across the full spectrum of target symptoms.

Research Gaps and Limitations

Clinical trials for Météoxane and its core components are relevant in trials assessing short-term or episodic symptom patterns. Follow-up durations were limited to just a few weeks in most key efficacy trials, meaning long-term effects are not fully established. Data for certain groups remain insufficient, particularly for older adults with multiple health conditions and for use in children or adolescents, as the core efficacy research was evaluated in primarily adult populations. The overall evidence base has noted specific limitations, including modest sample sizes and the absence of a large number of direct RCTs assessing the combination against placebo.

Key Studies & References

1. Simethicone for the treatment of upper gastrointestinal diseases: systematic review and meta-analysis

Common questions about Météoxane (FAQ)

Q: What is Météoxane used for?

Météoxane is used to treat bloating and abdominal distension related to gas accumulation in the intestines. It is often prescribed for individuals experiencing discomfort and swelling due to excessive intestinal gas.

Q: What are the main ingredients in Météoxane?

Météoxane contains two main active substances:

• Phloroglucinol: This ingredient helps to relax the smooth muscles of the digestive and urinary tracts, which can help relieve spasms associated with pain and discomfort.
• Simeticone: This ingredient is an anti-foaming agent that works in the stomach and intestines to break up gas bubbles, making them easier to pass and reducing bloating.

Q: Can Météoxane be taken with other medications?

It is important to discuss all medications and supplements you are taking with your doctor or pharmacist before starting Météoxane. While no known major interactions are widely reported, professional advice ensures safe use, especially regarding absorption or effect on other digestive system treatments.

Q: How long does it take for Météoxane to work?

The time Météoxane takes to work can vary among individuals. The simeticone component typically begins to act quickly by breaking down gas bubbles soon after ingestion. Relief from symptoms of bloating and gas may be noticeable within a relatively short period, often within hours of taking the first dose. However, consistent use as directed may be needed for full symptom management.

Q: What should I do if I forget to take a dose of Météoxane?

If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one. If you are unsure, consult your pharmacist or doctor.

How to Store and Dispose of Météoxane?

Storage Requirements

Météoxane soft capsules do not require any special storage conditions to remain stable throughout their documented shelf life of 3 years. The medicine must, however, be kept out of the sight and reach of children to prevent accidental ingestion, as required by official labeling.

Disposal Instructions

Official regulations prohibit the disposal of Météoxane via wastewater or household waste. This measure is mandatory to help protect the environment.

To discard unused or expired capsules properly, the medicine must be returned to a pharmacy or local waste disposal company authorized to handle pharmaceutical waste. This ensures safe and appropriate environmental handling.